Charlotte W. Duinkerken

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Maartje W. Rohaan, Raquel Gomez-Eerland, Joost H. van den Berg et al. · Immuno-Oncology Technology · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +17

Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial

Charlotte W. Duinkerken, Vincent A. de Weger, Wouter A. Dreschler et al. · Otology & Neurotology · 2021 · 26 citations · Full text

Medicine, Otolaryngology, Pharmacology +17

Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile

Charlotte W. Duinkerken, Peter J. F. M. Lohuis, Wilma D. Heemsbergen et al. · The Laryngoscope · 2016 · 17 citations

Medicine, Oncology, Radiation Oncology +13

Sensorineural Hearing Loss After Adoptive Cell Immunotherapy for Melanoma Using MART-1 Specific T Cells: A Case Report and Its Pathophysiology

Charlotte W. Duinkerken, Maartje W. Rohaan, Vincent A. de Weger et al. · Otology & Neurotology · 2019 · 14 citations · Full text

Medicine, Immunology, Otolaryngology +17

Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area

Charlotte W. Duinkerken, Peter J. F. M. Lohuis, Marianne B. Crijns et al. · Journal of Cutaneous Medicine and Surgery · 2016 · 11 citations

Medicine, Oncology, Radiation Oncology +13